Yancheng Donggang Pharmaceutical Development Co., Ltd. Sustainability Profile
Yancheng Donggang Pharmaceutical Development Co., Ltd., commonly referred to as Donggang Pharma, is a prominent player in the pharmaceutical industry, headquartered in Yancheng, Jiangsu Province, China. Established in 2001, the company has made significant strides in drug development and manufacturing, focusing on active pharmaceutical ingredients (APIs) and intermediates. With a strong presence in both domestic and international markets, Donggang Pharma is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of APIs, which are distinguished by their high purity and compliance with global regulatory standards. Over the years, Donggang Pharma has achieved notable milestones, solidifying its position as a trusted partner in the pharmaceutical supply chain.
DitchCarbon Score
How does Yancheng Donggang Pharmaceutical Development Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yancheng Donggang Pharmaceutical Development Co., Ltd.'s score of 5 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Yancheng Donggang Pharmaceutical Development Co., Ltd.'s reported carbon emissions
Yancheng Donggang Pharmaceutical Development Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Yancheng Donggang Pharmaceutical Development Co., Ltd. aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their carbon footprints and set ambitious targets in line with global climate goals. In summary, without available emissions data or climate commitments, Yancheng Donggang Pharmaceutical Development Co., Ltd. currently lacks transparency in its environmental impact and sustainability efforts.
How Carbon Intensive is Yancheng Donggang Pharmaceutical Development Co., Ltd.'s Industry?
How Carbon Intensive is Yancheng Donggang Pharmaceutical Development Co., Ltd.'s Location?
Yancheng Donggang Pharmaceutical Development Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Yancheng Donggang Pharmaceutical Development Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
